What are the results of the Hepatitis A IgM (Immunoglobulin M) antibody, Hepatitis B surface antigen (HBsAg), Hepatitis B core antibody total (HBcAb Tot), and Hepatitis C antibody (HepC Ab) tests?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The interpretation of hepatitis serological markers, including Hepatitis A IgM, HBsAg, HBcAb Total, and Hepatitis C antibody, requires a comprehensive understanding of the different phases of viral hepatitis infections and the corresponding serologic markers. Hepatitis A IgM antibody indicates a current or recent Hepatitis A infection. HBsAg (Hepatitis B surface antigen) is a marker for active Hepatitis B infection. HBcAb Total (Hepatitis B core antibody) indicates previous or ongoing Hepatitis B infection. Hepatitis C antibody suggests exposure to Hepatitis C virus. Without specific test results provided, I cannot give a definitive interpretation. If these tests are positive, consultation with a healthcare provider is necessary for proper diagnosis and management, as indicated by the guidelines from the Advisory Committee on Immunization Practices 1. Treatment depends on which virus is causing the infection and may include supportive care for Hepatitis A, antiviral medications for chronic Hepatitis B (such as entecavir or tenofovir), or direct-acting antivirals for Hepatitis C (such as sofosbuvir/velpatasvir) 1. Viral hepatitis can cause liver inflammation and potentially lead to chronic liver disease, so proper diagnosis and treatment are essential for preventing complications. The diagnosis and management of hepatitis B infection have been reviewed and include assays for determining viral genotype, detection of genotypic drug resistance mutations, and core promoter/precore mutations 1. The interpretation of serologic markers for HBV infection, including HBsAg, anti-HBs, IgM anti-HBc, and IgG anti-HBc, can distinguish acute, chronic, or prior infection, as well as confirm immunity in individuals who have been vaccinated 1. The presence of anti-HBs is generally indicative of immunity to HBV infection, and anti-HBs levels of ≥10 mIU/mL are generally considered seroprotective 1. In certain persons, anti-HBc is the only serologic marker detected, and isolated anti-HBc-positivity can be detected following HBV infection in persons who have recovered but whose anti-HBs levels have waned 1. The diagnosis of hepatitis C virus (HCV) infection usually begins with a screening test for HCV IgG antibody in serum or plasma immunoassays, and individuals with positive HCV IgG antibody screening test results should undergo confirmatory or supplemental testing for HCV RNA by molecular test methods 1.

Some key points to consider in the interpretation of hepatitis serological markers include:

  • The presence of HBsAg indicates current HBV infection, either acute or chronic.
  • The presence of anti-HBc indicates previous or ongoing HBV infection.
  • The presence of anti-HBs indicates immunity to HBV infection.
  • The presence of HCV IgG antibody indicates exposure to HCV.
  • The presence of HCV RNA indicates current HCV infection.
  • The interpretation of serologic markers should be done in the context of the patient's clinical presentation and medical history.
  • Consultation with a healthcare provider is necessary for proper diagnosis and management of hepatitis infections.

In terms of treatment, the goal is to prevent complications and improve quality of life, and the choice of treatment depends on the specific virus causing the infection and the severity of the disease. For example, antiviral medications such as entecavir or tenofovir may be used to treat chronic Hepatitis B, while direct-acting antivirals such as sofosbuvir/velpatasvir may be used to treat Hepatitis C 1. In addition, supportive care such as rest, hydration, and nutrition may be necessary to manage symptoms and prevent complications. Overall, the interpretation of hepatitis serological markers requires a comprehensive understanding of the different phases of viral hepatitis infections and the corresponding serologic markers, as well as consultation with a healthcare provider for proper diagnosis and management.

From the Research

Hepatitis Markers

  • HepA IgM: Indicates acute hepatitis A infection 2
  • HBsAg:
    • Positive result indicates current hepatitis B infection 3, 4, 5
    • Levels of HBsAg can help differentiate between acute and chronic hepatitis B infection 4
  • HBcAb Tot:
    • Indicates exposure to hepatitis B virus 3, 4, 5
    • Can be positive in both acute and chronic hepatitis B infection 4
  • HepC Ab:
    • Indicates exposure to hepatitis C virus 3, 5, 6
    • Can be positive in both acute and chronic hepatitis C infection 5

Interpretation of Hepatitis Markers

  • The presence of HBsAg and IgM anti-HBc indicates acute hepatitis B infection 4, 5
  • The presence of HBsAg and anti-HBc (without IgM) indicates chronic hepatitis B infection 4, 5
  • The presence of anti-HCV and HCV RNA indicates hepatitis C infection 5
  • The interpretation of hepatitis markers can be complex and may require additional testing, such as HCV genotyping and HBV DNA testing 5, 6

Clinical Significance

  • Acute hepatitis A infection is usually self-limiting, but can cause severe illness in some cases 2
  • Chronic hepatitis B and C infections can lead to liver cirrhosis and hepatocellular carcinoma 3, 6
  • Early diagnosis and treatment of hepatitis B and C infections can improve outcomes and prevent transmission 3, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hepatitis A virus infection.

Nature reviews. Disease primers, 2023

Research

Acute and chronic viral hepatitis.

Lippincott's primary care practice, 1998

Research

Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2006

Research

[Laboratory diagnosis of viral hepatitis B and C].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.